Streamline the formulary decision making process
FormularyDecisions is a secure online platform that facilitates the exchange of information between payers and life sciences companies to provide healthcare decision makers with the evidence, resources, and tools to support the product evaluation process. With FormularyDecisions, you can quickly access the information you need on thousands of products all from one site.
Acquire product information early
Enhance the way you gather product data via a single, secure 24/7 platform. There are over 3,000 FDA-approved and pipeline products on the platform. Gain compliant access to the information you deem most critical when considering formulary decisions. In addition, there are over 1 million evidence links to leading scientific resources including FDA, CDC, NIH, JAMA, PubMed, and more – offering you a more efficient method to source information in support of your product needs.
Evaluate competitive evidence
With FormularyDecisions, you can quickly compare multiple products within a product class. Drug Class Reviews are available to evaluate indications, mechanisms of action, dosing, and adverse events for similar agents.
Understand the US biosimilars market and laws governing every state
Gain centralized access to all pertinent biosimilar information in the US through the biosimilars hub. The hub provides FDA guidance on biosimilars, manufacturer resources, and serves as an exclusive repository for substitution laws for all 50 states.
Connect with manufacturers
More than 500 manufacturers (pharma, biotech, medical device) are featured on the platform providing information that includes disease and therapeutic information, abstracts, posters, monographs, and pivotal clinical studies. eDossiers allow users
to automatically access manufacturer product information once it becomes
available and easily create customized product monographs.
Determine the cost effectiveness of products
FormularyDecisions is also the home to reports generated by the Institute for Clinical and Economic Review (ICER). ICER Reports assist decision makers in determining the cost effectiveness of products in specific disease states as compared to similar products.
FormularyDecisions for healthcare decision makers feature highlight:
Clinical Guidelines Snapshot
Our new Clinical Guideline Snapshots feature makes finding expert summaries of published clinical guidelines easy. We’ve partnered with the clinical experts at The Medical Letter to provide you with all the latest product and disease state updates you need to know — summarized for you in one convenient place.